CMA closes final covid-19 excessive pricing case
The UK’s Competition and Markets Authority has dropped its fourth and final coronavirus-linked excessive pricing probe, after concluding that the prices charged by a pharmacy were unlikely to have breached competition rules.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now